What is new in ISO 14971 2019

Поделиться
HTML-код
  • Опубликовано: 3 дек 2024

Комментарии • 10

  • @jonathanphillips5514
    @jonathanphillips5514 4 года назад +1

    Excellent video. In the process of updating a number of risk management files and starting a brand new one!

    • @MedicalDeviceHQ
      @MedicalDeviceHQ  4 года назад

      Jonathan Phillips thanks for the kind words. I hope the video helps. And the checklist if you download it. Let me know if you think something is missing.

    • @jonathanphillips5514
      @jonathanphillips5514 4 года назад

      @@MedicalDeviceHQ Nothing missing as was comprehensive as you can be in that time. I do have a question regarding clinical evaluation...can you advise on any training material or courses? Thanks

  • @engr.emmanuelenyi8921
    @engr.emmanuelenyi8921 4 года назад +1

    Great job! Quite informative. How may we estaminate risk to the barest minimum?

  • @KrishnaChaitanyakc9
    @KrishnaChaitanyakc9 4 года назад +1

    Very well done . Thank you

  • @DoaaKhalil611
    @DoaaKhalil611 4 года назад +1

    I want to know how to perform risk benefit analysis ??

  • @ramakrishnahavaldar9513
    @ramakrishnahavaldar9513 4 года назад +1

    Hi Peter,
    The presentation is very informative and thanks for sharing.
    I wanted to understand, as a part of new 2019 version of the standard, should we have to specifically list out the reasonably foreseeable misuses about the product?
    If yes, where should it be? Is it as a part of intended use & indications of use of the product OR in the Risk management Review file?
    Please let us know.

    • @MedicalDeviceHQ
      @MedicalDeviceHQ  3 года назад

      I would say that we have always been documenting the reasonably foreseeable misuse. That is part of the risk analysis. I would not expect a separate list with just that.

  • @lovkeshsingh1140
    @lovkeshsingh1140 4 года назад

    Good video really appreciated